4//SEC Filing
Mercier Johanna 4
Accession 0001782135-25-000004
CIK 0000882095other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 6:31 PM ET
Size
8.3 KB
Accession
0001782135-25-000004
Insider Transaction Report
Form 4
Mercier Johanna
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-09-10−3,844→ 31,516 total→ Common Stock (3,844 underlying) - Tax Payment
Common Stock
2025-09-10$115.25/sh−1,819$209,640→ 116,193 total - Exercise/Conversion
Common Stock
2025-09-10+3,844→ 118,012 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001782135
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 6:31 PM ET
- Size
- 8.3 KB